• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环肿瘤细胞与单一转移活检中外显子测序在乳腺癌中应用的可行性初步研究。

A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.

机构信息

Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.

出版信息

Int J Mol Sci. 2020 Jul 8;21(14):4826. doi: 10.3390/ijms21144826.

DOI:10.3390/ijms21144826
PMID:32650480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7402350/
Abstract

The comparison of the landscape of somatic alterations in circulating tumor cells (CTCs) versus metastases is challenging. Here, we comprehensively characterized the somatic landscape in bulk (amplified and non-amplified), spike-in breast cancer cells, CTCs, and metastases from breast cancer patients using whole-exome sequencing (WES). We determined the level of genomic concordance for somatic nucleotide variants (SNVs), copy number alterations (CNAs), and structural variants (SVs). The variant allele fractions (VAFs) of somatic variants were remarkably similar between amplified and non-amplified cell line samples as technical replicates. In clinical samples, a significant fraction of somatic variants had low VAFs in CTCs compared to metastases. The most frequently recurrent gene mutations in clinical samples were associated with an elevated C > T mutational signature. We found complex rearrangement patterns including intra- and inter-chromosomal rearrangements, singleton, and recurrent gene fusions, and tandem duplications. We observed high molecular discordance for somatic alterations between paired samples consistent with marked heterogeneity of the somatic landscape. The most prevalent copy number calls were focal deletion events in CTCs and metastases. Our results demonstrate the feasibility of an integrated workflow for the identification of a complete repertoire of somatic alterations and highlight the intrapatient genomic differences that occur between CTCs and metastases.

摘要

比较循环肿瘤细胞 (CTC) 和转移灶中的体细胞改变的图谱具有挑战性。在这里,我们使用全外显子组测序 (WES) 全面表征了大量 (扩增和非扩增)、掺入乳腺癌细胞、CTC 和乳腺癌患者转移灶中的体细胞图谱。我们确定了体细胞核苷酸变异 (SNV)、拷贝数改变 (CNA) 和结构变异 (SV) 的基因组一致性水平。作为技术重复,扩增和非扩增细胞系样本中的体细胞变异的等位基因变异分数 (VAF) 非常相似。在临床样本中,与转移灶相比,CTC 中的体细胞变异的 VAF 有相当一部分较低。临床样本中最常出现的基因突变与 C > T 突变特征升高有关。我们发现了复杂的重排模式,包括染色体内和染色体间重排、单峰和复发性基因融合以及串联重复。我们观察到配对样本之间的体细胞改变存在高度的分子不一致性,这与体细胞图谱的明显异质性一致。最常见的拷贝数调用是 CTC 和转移灶中的局灶性缺失事件。我们的结果证明了用于鉴定完整的体细胞改变谱的集成工作流程的可行性,并强调了 CTC 和转移灶之间发生的患者内基因组差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/898f42630e37/ijms-21-04826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/3d6d2baef3ad/ijms-21-04826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/bf7891ebd428/ijms-21-04826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/f39cace4b3d4/ijms-21-04826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/898f42630e37/ijms-21-04826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/3d6d2baef3ad/ijms-21-04826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/bf7891ebd428/ijms-21-04826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/f39cace4b3d4/ijms-21-04826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc58/7402350/898f42630e37/ijms-21-04826-g004.jpg

相似文献

1
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.循环肿瘤细胞与单一转移活检中外显子测序在乳腺癌中应用的可行性初步研究。
Int J Mol Sci. 2020 Jul 8;21(14):4826. doi: 10.3390/ijms21144826.
2
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms.存档循环乳腺癌肿瘤细胞中的全面突变和拷贝数分析揭示了异质性耐药机制。
Cancer Res. 2018 Feb 15;78(4):1110-1122. doi: 10.1158/0008-5472.CAN-17-2686. Epub 2017 Dec 12.
3
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.通过转移性前列腺癌循环肿瘤细胞的全外显子组测序,获得转移性突变内容的一种可及且独特的见解。
Eur Urol Oncol. 2020 Aug;3(4):498-508. doi: 10.1016/j.euo.2018.12.005. Epub 2019 Jan 4.
4
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.治疗初发同步性原发性乳腺癌及其转移灶的遗传异质性。
Clin Cancer Res. 2017 Aug 1;23(15):4402-4415. doi: 10.1158/1078-0432.CCR-16-3115. Epub 2017 Mar 28.
5
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.对多发性骨髓瘤的游离 DNA 和循环肿瘤细胞进行全外显子组测序。
Nat Commun. 2018 Apr 27;9(1):1691. doi: 10.1038/s41467-018-04001-5.
6
Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.单细胞水平局部高危前列腺癌循环肿瘤细胞的基因组分析。
Cells. 2020 Aug 8;9(8):1863. doi: 10.3390/cells9081863.
7
A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.使用全基因组测序对前列腺癌中分离的循环肿瘤细胞和组织活检进行比较。
Oncotarget. 2015 Dec 29;6(42):44781-93. doi: 10.18632/oncotarget.6330.
8
Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.对有肝转移的乳腺癌患者循环肿瘤细胞进行全基因组拷贝数分析。
Oncol Rep. 2020 Sep;44(3):1075-1093. doi: 10.3892/or.2020.7650. Epub 2020 Jun 18.
9
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.转移性乳腺癌患者循环肿瘤细胞中单细胞水平PIK3CA突变状态的异质性。
Mol Oncol. 2015 Apr;9(4):749-57. doi: 10.1016/j.molonc.2014.12.001. Epub 2014 Dec 9.
10
Comparative genomic analysis of primary tumors and metastases in breast cancer.乳腺癌原发肿瘤与转移灶的比较基因组分析。
Oncotarget. 2016 May 10;7(19):27208-19. doi: 10.18632/oncotarget.8349.

引用本文的文献

1
Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics.循环肿瘤细胞:病理、分子和功能特征。
Int J Mol Sci. 2024 Jul 27;25(15):8198. doi: 10.3390/ijms25158198.
2
A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer.铜死亡相关长链非编码RNA特征预测乳腺癌预后并为未来抗肿瘤药物研发提供依据。
Transl Cancer Res. 2023 Jun 30;12(6):1392-1410. doi: 10.21037/tcr-22-2702. Epub 2023 Jun 21.
3
Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancer.

本文引用的文献

1
Detecting heterogeneity in and between breast cancer cell lines.检测乳腺癌细胞系内部以及不同细胞系之间的异质性。
Cancer Converg. 2020;4(1):1. doi: 10.1186/s41236-020-0010-1. Epub 2020 Feb 3.
2
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.CNApp,一种用于拷贝数改变定量分析和综合分析揭示临床意义的工具。
Elife. 2020 Jan 15;9:e50267. doi: 10.7554/eLife.50267.
3
New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
一种从转移性乳腺癌女性血液中捕获的循环肿瘤细胞(CTC)进行高度多重基因表达分析的新方法。
J Transl Med. 2023 Jun 26;21(1):414. doi: 10.1186/s12967-023-04242-z.
4
Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting.循环肿瘤细胞的检测与分子特征分析:临床环境面临的挑战
Cancers (Basel). 2023 Apr 6;15(7):2185. doi: 10.3390/cancers15072185.
5
Technologies for Viable Circulating Tumor Cell Isolation.循环肿瘤细胞分离的可行性技术。
Int J Mol Sci. 2022 Dec 15;23(24):15979. doi: 10.3390/ijms232415979.
6
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix PC1 System.一项使用Parsortix PC1系统从转移性乳腺癌患者中获取循环肿瘤细胞并进行特征分析的多中心临床研究。
Cancers (Basel). 2022 Oct 26;14(21):5238. doi: 10.3390/cancers14215238.
7
Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers.单循环肿瘤细胞全基因组扩增以揭示癌症异质性和可行的生物标志物。
Int J Mol Sci. 2022 Jul 29;23(15):8386. doi: 10.3390/ijms23158386.
8
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.早期三阴性乳腺癌患者原发肿瘤组织和循环肿瘤细胞的拷贝数改变分析。
Sci Rep. 2022 Jan 27;12(1):1470. doi: 10.1038/s41598-022-05502-6.
新型迷路微流控装置检测肝癌中表达癌症干细胞标志物的循环肿瘤细胞和循环肿瘤微栓子。
Sci Rep. 2019 Dec 9;9(1):18575. doi: 10.1038/s41598-019-54960-y.
4
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.高通量测序揭示了血浆游离循环 DNA 变异体的来源。
Nat Med. 2019 Dec;25(12):1928-1937. doi: 10.1038/s41591-019-0652-7. Epub 2019 Nov 25.
5
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.通过对循环肿瘤细胞的单细胞分析来揭示肿瘤异质性。
Nat Rev Cancer. 2019 Oct;19(10):553-567. doi: 10.1038/s41568-019-0180-2. Epub 2019 Aug 27.
6
The role of clonal communication and heterogeneity in breast cancer.克隆通讯和异质性在乳腺癌中的作用。
BMC Cancer. 2019 Jul 5;19(1):666. doi: 10.1186/s12885-019-5883-y.
7
Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells.Hydro-Seq 可实现无污染的高通量循环肿瘤细胞单细胞 RNA 测序。
Nat Commun. 2019 May 15;10(1):2163. doi: 10.1038/s41467-019-10122-2.
8
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.比较 TCGA 和 GENIE 基因组数据集,以检测乳腺癌中的临床可操作改变。
Sci Rep. 2019 Feb 6;9(1):1482. doi: 10.1038/s41598-018-37574-8.
9
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.
10
DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes.DNA 断裂点分析显示,大多数大片段重复发生在串联重复中,从而减少了乳腺癌易感性基因中的 VUS 分类。
Genet Med. 2019 Mar;21(3):683-693. doi: 10.1038/s41436-018-0092-7. Epub 2018 Jul 28.